Advertisement

Topics

Celgene set to challenge Incyte and Novartis in the myelofibrosis landscape

04:54 EST 11 Jan 2018 | Pharmaceutical Technology

On January 7th 2018, Celgene and Impact Biomedicines announced the signing of a definitive agreement in which Celgene will acquire...
Read More...

The post Celgene set to challenge Incyte and Novartis in the myelofibrosis landscape appeared first on Pharmaceutical Technology.

Original Article: Celgene set to challenge Incyte and Novartis in the myelofibrosis landscape

NEXT ARTICLE

More From BioPortfolio on "Celgene set to challenge Incyte and Novartis in the myelofibrosis landscape"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...